MicroRNA-222 promotes the proliferation and migration of cervical cancer cells

Clinical and Investigative Medicine

Volumn 37, Issue 3, 2014, Pages 131-141

  Sun, Yi ^a   Zhang, Bo ^a   Cheng, Jiajing ^a   Wu, Yi ^a   Xing, Fing ^a   Wang, Yingyi ^a   Wang, Qingying ^a   Qiu, Jin ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN222 MICRORNA, HUMAN;

CELL MOTION; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; HELA CELL LINE; HUMAN; PHYSIOLOGY; UTERINE CERVIX TUMOR;

CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HELA CELLS; HUMANS; MICRORNAS; MICROSCOPY, FLUORESCENCE; UTERINE CERVICAL NEOPLASMS;

EID: 84902175120     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: 10.25011/cim.v37i3.21380     Document Type: Article

References (25)

1. Lu D, Qian J, Yin X, Xiao Q, Wang C, Zeng Y. Expression of PTEN and survivin in cervical cancer: promising biological markers for early diagnosis and prognostic evaluation. British Journal of Biomedical Science. 2012;69(4):143-146.
2. Moukova L, Nenutil R, Fabian P, Chovanec J. [Prognostic factors for cervical cancer]. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti. 2013;26(2):83-90.
3. Sevignani C, Calin GA, Siracusa LD, Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mammalian genome: offcial journal of the International Mammalian Genome Society. 2006;17(3):189-202. doi: 10.1007/s00335-005-0066-3.
4. Naeini MM, Ardekani AM. Noncoding RNAs and cancer. Avicenna Journal of Medical Biotechnology. 2009;1(2):55-70.
5. Su X, Xing J, Wang Z, Chen L, Cui M, Jiang B. microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. Chinese Journal of Cancer Research = Chung-kuo yen cheng yen chiu. 2013;25(2):235-239. doi: 10.3978/j.issn.1000-9604.2013.03.08.
6. Garofalo M, Ffuintavalle C, Romano G, Croce CM, Condorelli G. miR221/222 in cancer: their role in tumor progression and response to therapy. Current Molecular Medicine. 2012;12(1):27-33.
7. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif ). 2001;25(4):402-408. doi: 10.1006/meth.2001.1262.
8. Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, Croce CM. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell. 2009;16(6):498-509. doi: 10.1016/j.ccr.2009.10.014.
9. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(9):2999-3004. doi: 10.1073/pnas.0307323101.
10. Garofalo M, Condorelli G, Croce CM. MicroRNAs in diseases and drug response. Current Opinion in Pharmacology. 2008;8(5):661-667. doi: 10.1016/j.coph.2008.06.005.
11. Garofalo M, Condorelli GL, Croce CM, Condorelli G. MicroRNAs as regulators of death receptors signaling. Cell Death and Differentiation. 2010;17(2):200-208. doi: 10.1038/cdd.2009.105.
12. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Molecular Medicine. 2012;4(3):143-159. doi: 10.1002/emmm.201100209.
13. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors deffnes cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(7):2257-2261. doi: 10.1073/pnas.0510565103.
14. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafre SA, Farace MG. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. The Journal of Biological Chemistry. 2007;282(32):23716-23724. doi: 10.1074/jbc.M701805200.
15. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafre SA, Farace MG, Agami R. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. the EMBO Journal. 2007;26(15):3699-3708. doi: 10.1038/sj.emboj.7601790.
16. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM, Fusco A. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocrine-Related Cancer. 2007;14(3):791-798. doi: 10.1677/erc-07-0129.
17. Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. Journal of the National Cancer Institute. 2010;102(10):706-721. doi: 10.1093/jnci/djq102.
18. Garofalo M, Ffuintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM, Condorelli G. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene. 2008;27(27):3845-3855. doi: 10.1038/onc.2008.6.
19. Perkins JR, Dawes JM, McMahon SB, Bennett DL, Orengo C, Kohl M. ReadqPCR and NormqPCR: R packages for the reading, quality checking and normalisation of RT-qPCR quantification cycle (Cq) data. BMC Genomics. 2012;13:296. doi: 10.1186/1471-2164-13-296.
20. Sivakolundu SG, Bashford D, Kriwacki RW. Disordered p27Kip1 exhibits intrinsic structure resembling the Cdk2/cyclin A-bound conformation. Journal of Molecular Biology. 2005;353(5):1118-1128. doi: 10.1016/j.jmb.2005.08.074.
21. Piva R, Cancelli I, Cavalla P, Bortolotto S, Dominguez J, Draetta GF, Schiffer D. Proteasome-dependent degradation of p27/kip1 in gliomas. Journal of Neuropathology and Experimental Neurology. 1999;58(7):691-696.
22. Park MS, Rosai J, Nguyen HT, Capodieci P, Cordon-Cardo C, Koff A. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(11):6382-6387.
23. Lee SH, Kim JW, Oh SH, Kim YJ, Rho SB, Park K, Park KL, Lee JH. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer. FEBS Letters. 2005;579(5):1027-1033. doi: 10.1016/j.febslet.2005.01.005.
24. Kawauchi T. Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis. International Journal of Molecular Sciences. 2012;13(4):4564-4590. doi: 10.3390/ijms13044564.
25. Cunniffe C, Ryan F, Lambkin H, Brankin B. Expression of tight and adherens junction proteins in cervical neoplasia. British Journal of Biomedical Science. 2012;69(4):147-153.